Document is current
Any future updates will be listed below
-
Authors
Zhang, Yudi
Wu, Junying
Qin, Tiejun
Xu, Zefeng
Qu, Shiqiang
Pan, Lijuan
Li, Bing
Wang, Huijun
Zhang, Peihong
Yan, Xin
Gong, Jingye
Gao, Qingyan
Gale, Robert Peter http://orcid.org/0000-0002-9156-1676
Xiao, Zhijian http://orcid.org/0000-0002-1099-4489
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81870104, 81870104, 81870104)
Chinese Academy of Medical Sciences (2016-I2M-1-001, 2020-I2M-C&T-A-020, 2020-I2M-C&T-B-090, 2016-I2M-1-001, 2020-I2M-C&T-A-020, 2020-I2M-C&T-B-090, 2016-I2M-1-001, 2020-I2M-C&T-A-020, 2020-I2M-C&T-B-090)
Haihe Laboratory of Cell Ecosystem Innovation Fun
- License Information
-
More Information
Article History
Received: 21 July 2022
Revised: 15 September 2022
Accepted: 26 September 2022
First Online: 12 October 2022
Competing interests
: RPG is a consultant to NexImmune Inc. Nanexa Pharma, Ascentage Pharm Group and Antengene Biotech LLC, Medical Director of FFF Enterprises Inc.; Partner in AZAC Inc.; Board of Directors of Russian Foundation for Cancer Research Support and Scientific Advisory Board: StemRad Ltd. The other authors declare no competing interests.
